Finance

Lists
BLAU3:BVMF
Blau Farmaceutica SA
12,51 R$
0,00%
(0,00) 1D
14 қаз., 17:04:00 GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for BLAU3...
Open
12,33 R$
High
12,83 R$
Low
12,01 R$
Mkt. cap
2,92 млрд
Avg. vol.
292,48 м.
Volume
418,50 м.
Dividend
5,55%
Quarterly dividend
0,17 R$
Ex-dividend date
2025 ж. 19 жел.
P/E ratio
12,48
52-wk high
12,89 R$
52-wk low
8,22 R$
EPS
1,00 R$
Shares outstanding
233,21 млн
No. of employees
2 мың
Open
12,33 R$
High
12,83 R$
Low
12,01 R$
Mkt. cap
2,92 млрд
Avg. vol.
292,48 м.
Volume
418,50 м.
Dividend
5,55%
Quarterly dividend
0,17 R$
Ex-dividend date
2025 ж. 19 жел.
P/E ratio
12,48
52-wk high
12,89 R$
52-wk low
8,22 R$
EPS
1,00 R$
Shares outstanding
233,21 млн
No. of employees
2 мың
News stories
From web sources and news partners
About Blau Farmaceutica SA
CEOMarcelo Rodolfo Hahn
Employees1,9 мың
Founded1987
Headquarters-
Sector-
Websiteblau.com
Last report
2026 ж. 12 там.
Fiscal period
Q2 2026
0,31 R$ / 0,33 R$
-8,01%miss
Revenue / Est. (BRL)
486,60 млн / 497,66 млн
-2,22%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in BRL
Loading Previous Earnings...
Revenue
Net income
All values in BRL
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
475,20 млн
389,36 млн
434,97 млн
486,60 млн
Cost of goods sold
282,46 млн
235,99 млн
254,72 млн
274,60 млн
Cost of revenue
282,46 млн
235,99 млн
254,72 млн
274,60 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
90,17 млн
100,07 млн
94,55 млн
100,58 млн
Operating expense
101,15 млн
104,83 млн
95,01 млн
128,66 млн
Total operating expenses
383,61 млн
340,82 млн
349,73 млн
403,25 млн
Operating income
91,59 млн
48,54 млн
85,24 млн
83,34 млн
Other non operating income
-
-2,58 млн
-2,87 млн
-
EBT including unusual items
138,33 млн
44,19 млн
52,20 млн
65,45 млн
EBT excluding unusual items
138,33 млн
44,19 млн
52,20 млн
65,45 млн
Income tax expense
32,81 млн
6,81 млн
15,92 млн
9,91 млн
Effective tax rate
23,72%
15,41%
30,49%
15,15%
Other operating expenses
10,98 млн
4,76 млн
461,00 м.
28,08 млн
Net income
104,42 млн
36,25 млн
39,77 млн
53,39 млн
Net profit margin
21,97%
9,31%
9,14%
10,97%
Earnings per share
0,53
-
0,17
0,31
Interest and investment income
106,52 млн
9,95 млн
12,94 млн
18,65 млн
Interest expense
-59,77 млн
-22,99 млн
-21,35 млн
-36,54 млн
Net interest expenses
46,75 млн
-13,04 млн
-8,41 млн
-17,89 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
103,32 млн
62,47 млн
99,62 млн
98,53 млн
Gain or loss from assets sale
-
50,02 млн
-
-
AI content may include mistakes. Learn more
Google қолданбалары